CLVS : Insider Transactions for Clovis Oncology, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Clovis Oncology, Inc. (CLVS)

$0.02 0.00 (0.00%) as of 4:30 Mon 7/10

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

88,200,000

Market Cap:

1.32(M)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$0.0103 - $0.0388

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Biotechnology

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents. Co. markets Rubraca®, which is an oral small molecule inhibitor of poly ADP-ribose polymerase for indications specific to recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. Co.'s product candidates include: FAP-2286, a peptide-targeted radionuclide therapy and imaging agent targeting fibroblast activation protein; and Lucitanib, an oral potent angiogenesis inhibitor which inhibits vascular endothelial growth factor receptors 1 through 3, platelet-derived growth factor receptors alpha and beta and fibroblast growth factor receptors 1 through 3.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	0	0	0	60,798
Total Sell Value	$0	$0	$0	$67,533
Total People Sold	0	0	0	5
Total Sell Transactions	0	0	0	26
End Date	2024-02-15	2023-11-14	2023-05-16	2022-05-16

Adjust Filter Settings

Records found: 509

Page 18 of 21

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Spickschen Thorlef

Director

– • –

2018-02-22

4

AS

$60.00

$270,000

D/D

(4,500)

16,618

-

Ivers-Read Gillian C

See Remarks

• – –

2018-02-15

4

AS

$54.09

$162,270

D/D

(3,000)

180,571

-

Ivers-Read Gillian C

See Remarks

• – –

2018-01-16

4

AS

$59.16

$177,480

D/D

(3,000)

183,571

-

Spickschen Thorlef

Director

– • –

2018-01-08

4

AS

$64.97

$292,365

D/D

(4,500)

21,118

-

See Remarks

• – –

2017-12-20

4

D

$63.80

$440,858

D/D

(6,910)

6,840

-

See Remarks

• – –

2017-12-20

4

OE

$0.00

$0

D/D

13,750

13,750

-

Ivers-Read Gillian C

See Remarks

• – –

2017-12-20

4

D

$63.80

$224,066

D/D

(3,512)

186,571

-

Ivers-Read Gillian C

See Remarks

• – –

2017-12-20

4

OE

$0.00

$0

D/D

7,500

190,083

-

Ivers-Read Gillian C

See Remarks

• – –

2017-12-15

4

AS

$64.16

$192,480

D/D

(3,000)

182,583

-

Spickschen Thorlef

Director

– • –

2017-12-08

4

AS

$60.00

$270,000

D/D

(4,500)

25,618

-

See Remarks

• – –

2017-11-29

4

D

$59.49

$15,408

D/D

(259)

2,616

-

See Remarks

• – –

2017-11-29

4

OE

$0.00

$0

D/D

547

2,875

-

Hooks Corwin Dale

See Remarks

• – –

2017-11-29

4

D

$59.49

$19,691

D/D

(331)

2,687

-

Hooks Corwin Dale

See Remarks

• – –

2017-11-29

4

OE

$0.00

$0

D/D

868

3,018

-

Ivers-Read Gillian C

See Remarks

• – –

2017-11-15

4

AS

$63.70

$191,100

D/D

(3,000)

185,583

-

Ivers-Read Gillian C

See Remarks

• – –

2017-10-16

4

AS

$84.54

$253,620

D/D

(3,000)

188,583

-

Ivers-Read Gillian C

See Remarks

• – –

2017-09-15

4

AS

$69.50

$208,500

D/D

(3,000)

191,583

-

Hooks Corwin Dale

See Remarks

• – –

2017-08-31

4

S

$76.36

$164,174

D/D

(2,150)

19

-

Hooks Corwin Dale

See Remarks

• – –

2017-08-29

4/A

D

$72.14

$95,586

D/D

(1,325)

2,150

-

See Remarks

• – –

2017-08-29

4/A

D

$72.14

$51,219

D/D

(710)

2,328

-

See Remarks

• – –

2017-08-25

4

D

$73.16

$51,212

D/D

(700)

2,338

-

See Remarks

• – –

2017-08-25

4

OE

$0.00

$0

D/D

2,188

3,038

-

Hooks Corwin Dale

See Remarks

• – –

2017-08-25

4

D

$73.16

$95,547

D/D

(1,306)

2,169

-

Hooks Corwin Dale

See Remarks

• – –

2017-08-25

4

OE

$0.00

$0

D/D

3,475

3,475

-

Director

– • –

2017-08-16

4

A

$0.00

$0

I/I

6,477

9,404

-

509 Records found	Previous 10 11 12 13 14 15 16 17 18 19 Next	Page 18 of 21

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.